-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TMKVxZt1+kRGex4FiPyXxSTD+ltNSuoxJ7j8oagAKtvfsljtwxEU/CHsgy6Pd+ec lxmElGkCjYCvgnHOMYNUMg== 0001428369-11-000001.txt : 20110103 0001428369-11-000001.hdr.sgml : 20101231 20110103111428 ACCESSION NUMBER: 0001428369-11-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110103 DATE AS OF CHANGE: 20110103 EFFECTIVENESS DATE: 20110103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: THAR PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001428369 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-151589 FILM NUMBER: 11500745 BUSINESS ADDRESS: STREET 1: 730 WILLIAM PITT WAY CITY: PITTSBURGH STATE: PA ZIP: 15238 BUSINESS PHONE: 412-435-0200 MAIL ADDRESS: STREET 1: 730 WILLIAM PITT WAY CITY: PITTSBURGH STATE: PA ZIP: 15238 D/A 1 primary_doc.xml X0704 D/A LIVE 0001428369 THAR PHARMACEUTICALS INC 730 WILLIAM PITT WAY PITTSBURGH PA PENNSYLVANIA 15238 412-435-0200 DELAWARE None None Corporation true 2008 Raymond Houck c/o Thar Pharmaceuticals 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 15238 Executive Officer Director Lalit Chordia c/o Thar Pharmaceuticals, Inc. 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 15238 Director Philip Sussman c/o Thar Pharmaceuticals, Inc. 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 15238 Director Filip Amram c/o Thar Pharmaceuticals, Inc. 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 15238 Director Mazen Hanna c/o Thar Pharmaceuticals, Inc. 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 15238 Executive Officer Director Jason Bablak c/o Thar Pharmaceuticals, Inc. 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 15238 Executive Officer Brian Moyer c/o Thar Pharmaceuticals, Inc. 730 William Pitt Way Pittsburgh PA PENNSYLVANIA 15238 Executive Officer Pharmaceuticals Decline to Disclose 06 true 0001428369-10-000002 2010-11-29 false true true true false 100000 9636000 4311656 5324344 The total offering amount includes shares attributable to the sale of Series A-1 stock and warrants and the conversion of existing convertible debt. The final amount is subject to actual debt converted into shares and warrants exercised. false 5 0 0 796000 true A use of proceeds is working capital, which use includes salaries of executive officers. false THAR PHARMACEUTICALS INC Brian Moyer Brian Moyer Vice President, Corporate Development 2011-01-03 -----END PRIVACY-ENHANCED MESSAGE-----